Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-15 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
CALA | Calithera Biosciences | 2.88 | -0.02 | -0.69% | 203.2M |
You can purchase shares of Calithera Biosciences (NASDAQ: CALA) through any online brokerage.
Other companies in Calithera Biosciences’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Atossa Therapeutics (NASDAQ:ATOS) and Concert Pharmaceuticals (NASDAQ:CNCE).
The latest price target for Calithera Biosciences (NASDAQ: CALA) was reported by HC Wainwright & Co. on 2021-01-05. The analyst firm set a price target for 4.00 expecting CALA to rise to within 12 months (a possible 38.89% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Calithera Biosciences (NASDAQ: CALA) is $2.88 last updated Tue Mar 02 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Calithera Biosciences.
There is no upcoming split for Calithera Biosciences.